Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets
- Autores
- Brevedan, Marta Ingrid Victoria; Varillas, María Alejandra; González Vidal, Noelia Luján
- Año de publicación
- 2022
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Similarity studies are used with the intention to establish interchangeability of certain formulations in vitro, without the need to carry out in vivo studies. This interchangeability between formulations should be conserved during the product shelf life, as an integral part of the pharmaceutical stability. Hydrochlorothiazide (HCTZ), a widely used diuretic, is classified as a class 3 drug in the Biopharmaceutics Classification System (BCS). An immediate-release (IR) solid oral formulation containing a class 3 drug is a candidate for biowaiver if it meets the requirement of ῾very rapid dissolution’ (i.e., ≥ 85% dissolved within 15 minutes). This research aimed to compare four solid oral IR HCTZ formulations (50 mg), commercially available in Argentina, with respect to pharmaceutical similarity and stability. To assess for similarity, dissolution profiles were compared both at time zero (T0) and after 12 months of storage (T12) at pH 1.2, 4.5, and 6.8. To assess for stability, critical quality attributes (CQAs) of the samples were evaluated at T12 of storage (25 °C, 60% relative humidity). At T12, all samples met the requirements for CQAs (i.e., assay, friability, disintegration, uniformity, and dissolution). The reference formulation had the fastest dissolution rate, and sample D was the slowest. Two multisource formulations exhibited statistical differences with respect to the reference sample, both at T0 and T12. Because the evaluated multisource formulations did not meet criteria for very rapid dissolution, they are not candidates for biowaivers. In terms of stability, some statistical differences were detected between dissolution performance at T0 and T12 (for some samples and dissolution media), but no specific pattern could be detected. Thus, it can be considered that the storage conditions did not affect the critical quality attributes of evaluated samples, and their pharmaceutical equivalence was maintained.
Fil: Brevedan, Marta Ingrid Victoria. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
Fil: Varillas, María Alejandra. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
Fil: González Vidal, Noelia Luján. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina - Materia
-
BIOWAIVER
CRITICAL QUALITY ATTRIBUTES
DISSOLUTION
HYDROCHLOROTHIAZIDE (HCTZ)
STABILITY
STORAGE - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/217803
Ver los metadatos del registro completo
id |
CONICETDig_dae01cb3fb461ce3415f7f45ecdeba57 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/217803 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tabletsBrevedan, Marta Ingrid VictoriaVarillas, María AlejandraGonzález Vidal, Noelia LujánBIOWAIVERCRITICAL QUALITY ATTRIBUTESDISSOLUTIONHYDROCHLOROTHIAZIDE (HCTZ)STABILITYSTORAGEhttps://purl.org/becyt/ford/2.11https://purl.org/becyt/ford/2https://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3https://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1Similarity studies are used with the intention to establish interchangeability of certain formulations in vitro, without the need to carry out in vivo studies. This interchangeability between formulations should be conserved during the product shelf life, as an integral part of the pharmaceutical stability. Hydrochlorothiazide (HCTZ), a widely used diuretic, is classified as a class 3 drug in the Biopharmaceutics Classification System (BCS). An immediate-release (IR) solid oral formulation containing a class 3 drug is a candidate for biowaiver if it meets the requirement of ῾very rapid dissolution’ (i.e., ≥ 85% dissolved within 15 minutes). This research aimed to compare four solid oral IR HCTZ formulations (50 mg), commercially available in Argentina, with respect to pharmaceutical similarity and stability. To assess for similarity, dissolution profiles were compared both at time zero (T0) and after 12 months of storage (T12) at pH 1.2, 4.5, and 6.8. To assess for stability, critical quality attributes (CQAs) of the samples were evaluated at T12 of storage (25 °C, 60% relative humidity). At T12, all samples met the requirements for CQAs (i.e., assay, friability, disintegration, uniformity, and dissolution). The reference formulation had the fastest dissolution rate, and sample D was the slowest. Two multisource formulations exhibited statistical differences with respect to the reference sample, both at T0 and T12. Because the evaluated multisource formulations did not meet criteria for very rapid dissolution, they are not candidates for biowaivers. In terms of stability, some statistical differences were detected between dissolution performance at T0 and T12 (for some samples and dissolution media), but no specific pattern could be detected. Thus, it can be considered that the storage conditions did not affect the critical quality attributes of evaluated samples, and their pharmaceutical equivalence was maintained.Fil: Brevedan, Marta Ingrid Victoria. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; ArgentinaFil: Varillas, María Alejandra. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; ArgentinaFil: González Vidal, Noelia Luján. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; ArgentinaDissolution Technologies, Inc2022-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/217803Brevedan, Marta Ingrid Victoria; Varillas, María Alejandra; González Vidal, Noelia Luján; Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets; Dissolution Technologies, Inc; Dissolution Technologies; 29; 4; 11-2022; 1-91521-298XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://dissolutiontech.com/issues/202211/HCTZ.pdfinfo:eu-repo/semantics/altIdentifier/doi/10.14227/DT290422PGC1info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:11:29Zoai:ri.conicet.gov.ar:11336/217803instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:11:29.793CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets |
title |
Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets |
spellingShingle |
Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets Brevedan, Marta Ingrid Victoria BIOWAIVER CRITICAL QUALITY ATTRIBUTES DISSOLUTION HYDROCHLOROTHIAZIDE (HCTZ) STABILITY STORAGE |
title_short |
Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets |
title_full |
Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets |
title_fullStr |
Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets |
title_full_unstemmed |
Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets |
title_sort |
Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets |
dc.creator.none.fl_str_mv |
Brevedan, Marta Ingrid Victoria Varillas, María Alejandra González Vidal, Noelia Luján |
author |
Brevedan, Marta Ingrid Victoria |
author_facet |
Brevedan, Marta Ingrid Victoria Varillas, María Alejandra González Vidal, Noelia Luján |
author_role |
author |
author2 |
Varillas, María Alejandra González Vidal, Noelia Luján |
author2_role |
author author |
dc.subject.none.fl_str_mv |
BIOWAIVER CRITICAL QUALITY ATTRIBUTES DISSOLUTION HYDROCHLOROTHIAZIDE (HCTZ) STABILITY STORAGE |
topic |
BIOWAIVER CRITICAL QUALITY ATTRIBUTES DISSOLUTION HYDROCHLOROTHIAZIDE (HCTZ) STABILITY STORAGE |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/2.11 https://purl.org/becyt/ford/2 https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 https://purl.org/becyt/ford/1.4 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Similarity studies are used with the intention to establish interchangeability of certain formulations in vitro, without the need to carry out in vivo studies. This interchangeability between formulations should be conserved during the product shelf life, as an integral part of the pharmaceutical stability. Hydrochlorothiazide (HCTZ), a widely used diuretic, is classified as a class 3 drug in the Biopharmaceutics Classification System (BCS). An immediate-release (IR) solid oral formulation containing a class 3 drug is a candidate for biowaiver if it meets the requirement of ῾very rapid dissolution’ (i.e., ≥ 85% dissolved within 15 minutes). This research aimed to compare four solid oral IR HCTZ formulations (50 mg), commercially available in Argentina, with respect to pharmaceutical similarity and stability. To assess for similarity, dissolution profiles were compared both at time zero (T0) and after 12 months of storage (T12) at pH 1.2, 4.5, and 6.8. To assess for stability, critical quality attributes (CQAs) of the samples were evaluated at T12 of storage (25 °C, 60% relative humidity). At T12, all samples met the requirements for CQAs (i.e., assay, friability, disintegration, uniformity, and dissolution). The reference formulation had the fastest dissolution rate, and sample D was the slowest. Two multisource formulations exhibited statistical differences with respect to the reference sample, both at T0 and T12. Because the evaluated multisource formulations did not meet criteria for very rapid dissolution, they are not candidates for biowaivers. In terms of stability, some statistical differences were detected between dissolution performance at T0 and T12 (for some samples and dissolution media), but no specific pattern could be detected. Thus, it can be considered that the storage conditions did not affect the critical quality attributes of evaluated samples, and their pharmaceutical equivalence was maintained. Fil: Brevedan, Marta Ingrid Victoria. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina Fil: Varillas, María Alejandra. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina Fil: González Vidal, Noelia Luján. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina |
description |
Similarity studies are used with the intention to establish interchangeability of certain formulations in vitro, without the need to carry out in vivo studies. This interchangeability between formulations should be conserved during the product shelf life, as an integral part of the pharmaceutical stability. Hydrochlorothiazide (HCTZ), a widely used diuretic, is classified as a class 3 drug in the Biopharmaceutics Classification System (BCS). An immediate-release (IR) solid oral formulation containing a class 3 drug is a candidate for biowaiver if it meets the requirement of ῾very rapid dissolution’ (i.e., ≥ 85% dissolved within 15 minutes). This research aimed to compare four solid oral IR HCTZ formulations (50 mg), commercially available in Argentina, with respect to pharmaceutical similarity and stability. To assess for similarity, dissolution profiles were compared both at time zero (T0) and after 12 months of storage (T12) at pH 1.2, 4.5, and 6.8. To assess for stability, critical quality attributes (CQAs) of the samples were evaluated at T12 of storage (25 °C, 60% relative humidity). At T12, all samples met the requirements for CQAs (i.e., assay, friability, disintegration, uniformity, and dissolution). The reference formulation had the fastest dissolution rate, and sample D was the slowest. Two multisource formulations exhibited statistical differences with respect to the reference sample, both at T0 and T12. Because the evaluated multisource formulations did not meet criteria for very rapid dissolution, they are not candidates for biowaivers. In terms of stability, some statistical differences were detected between dissolution performance at T0 and T12 (for some samples and dissolution media), but no specific pattern could be detected. Thus, it can be considered that the storage conditions did not affect the critical quality attributes of evaluated samples, and their pharmaceutical equivalence was maintained. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-11 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/217803 Brevedan, Marta Ingrid Victoria; Varillas, María Alejandra; González Vidal, Noelia Luján; Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets; Dissolution Technologies, Inc; Dissolution Technologies; 29; 4; 11-2022; 1-9 1521-298X CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/217803 |
identifier_str_mv |
Brevedan, Marta Ingrid Victoria; Varillas, María Alejandra; González Vidal, Noelia Luján; Influence of storage conditions on pharmaceutical equivalence and similarity of hydrochlorothiazide tablets; Dissolution Technologies, Inc; Dissolution Technologies; 29; 4; 11-2022; 1-9 1521-298X CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://dissolutiontech.com/issues/202211/HCTZ.pdf info:eu-repo/semantics/altIdentifier/doi/10.14227/DT290422PGC1 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Dissolution Technologies, Inc |
publisher.none.fl_str_mv |
Dissolution Technologies, Inc |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842270160271966208 |
score |
13.13397 |